Vocxi Health
Arden Hills, US · Founded 2022 · 6 known investors
Find your way into Vocxi Health
381 people in our graph share verified history with the Vocxi Health team — schools, employers, funds. One of them is your warm intro.
Dan Gebremedhinunlockedknows Ping Yeh · together at UC San Diego (overlapped)
knows the team · via UC San Diego
×2knows the team · via Northwestern University - Kellogg School of Management
×3knows the team · via Seagate Technology
knows the team · via University of St. Thomas
×3knows the team · via UMN Carlson School of Management
Vocxi Health develops MyBreathPrint, a noninvasive breath-analysis device that detects volatile organic compounds to screen for lung cancer and other diseases early. The system uses nanotechnology and machine learning to provide immediate diagnostic results without needles, radiation, or surgery.
Founders & leadership
PY
Ping YehinChief Executive OfficerPing Yeh worked on solid-state drives at Seagate before transitioning to healthcare; he co-founded and built StemoniX to commercialize human brain tissue models for drug discovery, later became CEO of Vocxi Health to commercialize a breath-sensing diagnostic platform developed with Boston Scientific and the University of Minnesota, and is now co-founder and CEO of Person Health following its 2026 merger with Oncodea and RealBusiness AI.
GP
Greg PetersoninGreg Peterson has held leadership roles in medical devices and healthcare services at companies including Spinal Designs, E.I. duPont, Ecolab, Sheldahl, and IBM, and serves as director of Innovation Collaborations at the University of Minnesota's Medical Devices Center.
GS
Greg SherwoodChief Technology Officer
RS
Randy SchiestlNamed on SEC filing
YY
Yung-Ping YehNamed on SEC filing
Board
ME
Morgan EvansBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$4.7M disclosed across 2 rounds · 2022–2024
▶$800KraisedJul 2024 · 8 investors · Other Health CareRule 506(b)
▶$800KraisedJul 2024 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Morgan EvansDirector
- Greg SherwoodExecutive Officer, Director, Promoter
- Randy SchiestlExecutive Officer, Director, Promoter
- Yung-Ping YehExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Amount sold
- $800K
- Minimum investment
- $25K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$3.9MraisedSep 2023 · 13 investors · Other Health CareRule 506(b)
▶$3.9MraisedSep 2023 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Randy SchiestlExecutive Officer, Director
- Greg SherwoodExecutive Officer, Director
- Morgan EvansDirector
- Yung-Ping YehExecutive Officer, Director
- Offering amount
- $6.5M
- Amount sold
- $3.9M
- Minimum investment
- $25K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Vocxi Health do?
- Vocxi Health develops MyBreathPrint, a noninvasive breath-analysis device that detects volatile organic compounds to screen for lung cancer and other diseases early. The system uses nanotechnology and machine learning to provide immediate diagnostic results without needles, radiation, or surgery.
- Who are Vocxi Health's investors?
- Vocxi Health's investors include Alliance of Angels, Great North Ventures, GROOVE CAPITAL, Samsung Next, Taiwan Global Angels, Kitchen Fund.
- How much funding has Vocxi Health raised?
- Vocxi Health has disclosed $4.7M raised across 2 rounds.
- Where is Vocxi Health headquartered?
- Vocxi Health is headquartered in Arden Hills, US.